Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
about
Treatment of juvenile idiopathic arthritis: a revolution in careWhat does an adult rheumatologist need to know about juvenile idiopathic arthritis?HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia.2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.Update on the treatment of juvenile idiopathic arthritisRecent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritisChallenges in the management of juvenile idiopathic arthritis with etanerceptEvaluation and Treatment of Enthesitis-Related Arthritis.A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy.Enthesitis-related arthritis.The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.Juvenile idiopathic arthritis: management and therapeutic options.Disease activity patterns in juvenile systemic lupus erythematosus and its relation to early aggressive treatment.Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
P2860
Q26849497-CFF923F8-222D-4485-AE79-575CD729A48DQ26995394-89838E7F-62A2-4E75-92C3-62239C4D7C9BQ34244086-43DA377E-BC2C-48DA-BB0F-F495D9C61B3FQ35567870-1BDB2D71-8736-452C-B79B-53BF3C5ECC41Q37060351-5374E0AF-7320-4CBE-B8A0-EBF66FAF67A8Q37207120-74C2883D-FCBD-4502-836B-50805B0AADF1Q37303219-B34D5E50-4F67-4DD1-85BE-32D24253F363Q37438552-6258DC72-AA42-4724-93CD-2237D162DA56Q37627929-5A73E434-560A-4B66-B7B4-6E5CE27DD119Q37866288-A3D0207A-0AE3-4C13-A85E-BB7948708898Q38559051-2B3F04D8-01A2-4DB8-ADC6-CA4CEF5F43ADQ38672339-8AC2CBD6-0A99-4360-A435-2206AAB67C12Q39243858-E9FC4383-7ABE-411B-89CD-F9BB81BEDB4EQ42957622-E8E7F0DA-DF8E-425E-B951-18A6C533E9E5Q43689633-BB6F491A-3C42-4A0C-A635-050F91ED840D
P2860
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Long-term outcome of juvenile ...... early sulfasalazine treatment.
@ast
Long-term outcome of juvenile ...... early sulfasalazine treatment.
@en
type
label
Long-term outcome of juvenile ...... early sulfasalazine treatment.
@ast
Long-term outcome of juvenile ...... early sulfasalazine treatment.
@en
prefLabel
Long-term outcome of juvenile ...... early sulfasalazine treatment.
@ast
Long-term outcome of juvenile ...... early sulfasalazine treatment.
@en
P2093
P2860
P356
P1476
Long-term outcome of juvenile ...... early sulfasalazine treatment.
@en
P2093
Aeilko H Zwinderman
Ben A C Dijkmans
Dutch Juvenile Idiopathic Arthritis Study group
Johanna C M Oostveen
Lisette W A van Suijlekom-Smit
Maarten Boers
Marcel J A M Franssen
Marion A J van Rossum
Nico M Wulffraat
Rebecca ten Cate
P2860
P304
P356
10.1136/ARD.2006.064717
P407
P577
2007-05-09T00:00:00Z